Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10518605rdf:typepubmed:Citationlld:pubmed
pubmed-article:10518605lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:10518605lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10518605lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:10518605pubmed:issue21lld:pubmed
pubmed-article:10518605pubmed:dateCreated1999-12-2lld:pubmed
pubmed-article:10518605pubmed:abstractTextWe report hybridization properties of new phosphate-modified alpha-oligonucleoside analogs with non-ionic or cationic internucleotide linkages such as methoxy-ethylphosphoramidate (PNHME), phosphoromorpholi-date (PMOR) and dimethylaminopropylphosphor-amidate (PNHDMAP). First we evaluated the chirality effect of the phosphorus atom on the affinity of alpha- or beta-dodecanucleoside phosphodiesters containing one chirally enriched N -alkylphosphoramidate linkage located in the middle of the sequence d(TCTT-AA*CCCACA). As for P-substituted beta-oligonucleo-tides, a difference in binding behavior between the two diastereoisomers (difference in Delta T (m)) exists in the hybridization properties of alpha-analogs when DNA was the target but this effect was not detrimental to duplex stability. This effect was considerably reduced when RNA was the target. Secondly we studied the effect of steric hindrance around phosphorus on the affinity of fully modified beta- and alpha-oligonucleoside N -alkylphosphoramidates for their DNA and RNA targets. This effect was very weak with alpha-analogs whereas it was more pronounced with beta-oligos. PNHME-modified alpha-oligonucleosides formed more stable duplexes with DNA (Delta T (m)+9.6 degrees C) and RNA (Delta T (m)+1.4 degrees C) targets than the 'parent' phosphodiester. Finally, base pairing specificity of these alpha-oligonucleo-side N -alkylphosphoramidates for their targets was found to be as high as for natural oligonucleoside phosphodiesters.lld:pubmed
pubmed-article:10518605pubmed:languageenglld:pubmed
pubmed-article:10518605pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:citationSubsetIMlld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10518605pubmed:statusMEDLINElld:pubmed
pubmed-article:10518605pubmed:monthNovlld:pubmed
pubmed-article:10518605pubmed:issn1362-4962lld:pubmed
pubmed-article:10518605pubmed:authorpubmed-author:LaurentAAlld:pubmed
pubmed-article:10518605pubmed:authorpubmed-author:RaynesAAlld:pubmed
pubmed-article:10518605pubmed:authorpubmed-author:VasseurJ JJJlld:pubmed
pubmed-article:10518605pubmed:authorpubmed-author:DebartFFlld:pubmed
pubmed-article:10518605pubmed:authorpubmed-author:NavalMMlld:pubmed
pubmed-article:10518605pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10518605pubmed:day1lld:pubmed
pubmed-article:10518605pubmed:volume27lld:pubmed
pubmed-article:10518605pubmed:ownerNLMlld:pubmed
pubmed-article:10518605pubmed:authorsCompleteYlld:pubmed
pubmed-article:10518605pubmed:pagination4151-9lld:pubmed
pubmed-article:10518605pubmed:dateRevised2008-11-20lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:meshHeadingpubmed-meshheading:10518605...lld:pubmed
pubmed-article:10518605pubmed:year1999lld:pubmed
pubmed-article:10518605pubmed:articleTitleChiral and steric effects in the efficient binding of alpha-anomeric deoxyoligonucleoside N-alkylphosphoramidates to ssDNA and RNA.lld:pubmed
pubmed-article:10518605pubmed:affiliationLaboratoire de Chimie Organique Biomoléculaire de Synthèse, UMR 5625 CNRS-UM II, CC 008, Université Montpellier II, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France.lld:pubmed
pubmed-article:10518605pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10518605pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10518605lld:pubmed